Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

The U.S. Food and Drug Administration on Tuesday posted warning letters to 14 companies that are illegally selling more than 65 unproven cancer treatments.

FDA Warns Companies Selling Fraudulent Cancer Treatments

0
The unapproved products are often advertised as 'natural' and labeled as supplements
Biking to work may help lengthen lifespan

Cycling To and From Work Linked Lower CVD, Mortality Risk

0
In five-year study, cyclists saw risk for heart disease, cancer, early death cut by almost half
Cancer rates differ between African- and U.S.-born black Americans

Cancer Occurrence Differs Among African-Born, U.S.-Born Blacks

0
Research suggests differences in environmental, cultural, social, genetic factors
Enhanced patient-centered communication positively impacts patients' psychological state during bad-news encounters

Doctor Communication Style Key During Bad-News Encounters

0
Enhanced patient-centered communication lessens anxiety during disclosure of cancer diagnosis

American Association for Cancer Research, April 1-5

0
The American Association for Cancer Research Annual Meeting The annual meeting of the American Association for Cancer Research was held from April 1...
Childhood kidney recipients have increased cancer risk

Increased Cancer Risk for Childhood Kidney Recipients

0
Highest risk for standardized incidence ratios for lymphoproliferative disease and cervical cancer
As HIV becomes a lifetime disease instead of a fatal disease

AACR: Cancer Burden Changing for Americans With HIV

0
AIDS-linked tumors predicted to decline by 2030
Many survivors of childhood cancer have mutations in cancer-associated genes

AACR: Genetic Mutations Seen in Many Childhood Cancer Survivors

0
One in four children who lived through cancer developed another cancer by age 45, researchers say
Regular aspirin use is associated with reduced mortality

AACR: Regular Aspirin Use Linked to Lower Cancer Mortality

0
Regular aspirin use linked to lower risk of dying from cancer, especially colorectal, breast, prostate cancer
Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurrent epithelial ovarian

FDA Approves Zejula for Certain Female Cancers

0
PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum